Comparison of clozapine and haloperidol on some autonomie and psychomotor functions, and on serum prolactin concentration, in healthy subjects

British Journal of Clinical Pharmacology, Supplement

Volumn 52, Issue 3, 2001, Pages 322-326

  Pretorius, J L ^a   Phillips, M ^a   Langley, R W ^a   Szabadi, E ^a   Bradshaw, C M ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cardiovascular functions; Clozapine; Critical flicker fusion frequency; Haloperidol; Prolactin; Pupil; Salivation; Sedation

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; PROLACTIN;

ADULT; ANXIETY; ARTICLE; ATTENTION; AUTONOMIC NERVOUS SYSTEM; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART RATE; HUMAN; MALE; MIDDLE AGED; NEUROSECRETION; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; PUPIL; SALIVATION; TIME;

ADULT; ANTIPSYCHOTIC AGENTS; ANXIETY; ATTENTION; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CLOZAPINE; DOUBLE-BLIND METHOD; HALOPERIDOL; HEART RATE; HUMANS; MALE; MIDDLE AGED; NEUROSECRETORY SYSTEMS; PROLACTIN; PSYCHOMOTOR PERFORMANCE; PUPIL; SALIVATION; TIME FACTORS;

EID: 0035460056     PISSN: 02643774     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Dollery C. Tlicrapcntic Drugs, 2nd edn. Edinburgh. Churchill Livingstone, 1999.
2. Fulton B, Goa KL. Olanzapine. Drugs 1997; 53: 281-298.
3. Scatton D, Sanger DJ. Pharmacological and molecular targets in the search for novel antipsychotics. Behav Pharmocol 2000; 11: 243-256.
4. Pretorius L, Phillips M, Langley RW, Szabadi E, Bradshaw CM. Comparison of single doses of clozapine and haloperidol on autonomic, neuroendocrine and psychomotor functions in healthy subjects. J Psychopharmacol 2000; 14(Suppl 3): A57.
5. Taylor D, McConnell D, McConnell H, Abel K, Kenvin R. The Bethlem & Maudsley NHS Trust Prescribing Guidelines, 5th edn. London. Martin Dunitz, 1999.
6. British National Formulary Number 39. London: British Medical Association/Royal Pharmaceutical Society of Great Britain, 2000.
7. Phillips MA, Bitsios P, Szabadi E, Bradshaw CM. Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers. Psychopharmacol 2000; 149: 72-76.
8. Arya DK, Langley RW, Szabadi E, Bradshaw CM. Comparison of the effects of thermal stress and clonidine on autonomie functions in man. Naunyn-Schmiedeberg's Arch Pharmacol 1997; 355: 376-383.
9. Smith JM, Misiak H. Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects - a review. Psychopharmacol 1976; 47: 175-182.
10. Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Med Psychol 1974; 47:211-218.
11. Theofilopoulos N, Szabadi E, Bradshaw CM. Comparison of the effects of ranitidine, cimetidine and thioridazine on psychomotor functions in healthy volunteers. Br J Clin Pharmacol 1984; 18: 135-144.
12. Bitsios P, Szabadi E, Bradshaw CM. The inhibition of the pupillary light reflex by the threat of an electric shock: a potential laboratory model of human anxiety. J Psychopharmacol 1996; 10: 279-287.
13. Szabadi E, Tavernor S. Hypo- and hypersalivation induced by psychoactive drugs. CNS Drugs 1999; 11:449-466.
14. Abduljawad KAJ, Langley IUV, Bradshaw CM, Szabadi E. Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle ,eyeblink response and the N1/P2 auditory-evoked response in man. J Psychopharmacol 1999; 13: 3-9.